CareMax Faces Nasdaq Delisting Risk, Appoints New Director
Company Announcements

CareMax Faces Nasdaq Delisting Risk, Appoints New Director

The latest update is out from CareMax ( (CMAX) ).

CareMax, Inc. has been notified by Nasdaq that it no longer meets the minimum market value requirement for continued listing on the Nasdaq Global Select Market, having fallen short of the $15 million threshold over the past 30 days. The company has 180 days to comply by ensuring its shares reach and maintain the required market value for 10 consecutive business days. Concurrently, CareMax appointed Edward J. Borkowski as an independent Class II director for its board, where he will serve until the 2026 Annual Meeting of Stockholders and will be compensated $45,000 monthly. No related transactions involving Mr. Borkowski exceed the threshold of material interest set by the company.

For an in-depth examination of CMAX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyCareMax down 4% at $4.35 after Q2 results
TheFlyCareMax reports Q2 adjusted EBITDA ($11.2M) vs. $7.0M last year.
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App